Filing Details
- Accession Number:
- 0000939767-17-000149
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-14 19:18:31
- Reporting Period:
- 2017-09-12
- Accepted Time:
- 2017-09-14 19:18:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202106 | Lance Willsey | C/O Exelixis, Inc. 210 E. Grand Ave. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-09-12 | 50,000 | $26.79 | 518,273 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-09-13 | 50,000 | $26.97 | 468,273 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.59 to $26.94. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.81 to $27.29. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4
Billionaire Hedge Funds
